Sindjardi (emagliflosin + metformin hydrochloride) coated tablets 12.5 mg/1000 mg. №60


Manufacturer: Germany



Treatment of type 2 diabetes in adults as an adjunct to diet and exercise: if insufficient use of the maximum tolerated dose of metformin alone is sufficient; if the use of metformin in combination with other medicines for diabetes does not provide sufficient glycemic control; if patients are already receiving treatment with the combination of emagliflosin and metformin as separate drugs. Concerning the results of a study of combinations, effects on glycemic control, and cardiovascular disease.